Explore more publications!

Aruba Health Monitor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Health Monitor.

Press releases published on February 4, 2026

Max Force Power Male Enhancement Gummies Product Information Updated as Consumer Interest in Male Vitality Supplement Options Grows in 2026
Novarad to Attend 2026 Society of Interventional Oncology Annual Scientific Meeting in Savannah, Georgia
His Choice Health Launches Unified Men’s Health Brand After 10,000+ Vasectomy Procedures
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets
STERIS Announces Financial Results for Fiscal 2026 Third Quarter
Banner Health names new senior vice president of finance
The Ensign Group Reports Fiscal Year and Fourth Quarter 2025 Results; Issues 2026 Annual Earnings and Revenue Guidance
Relay Therapeutics to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
CC Pharma von Tilray als eines der 100 innovativsten Unternehmen in Deutschland ausgezeichnet
CC Pharma, filiale de Tilray, figure parmi le classement TOP 100 Innovator en Allemagne
New NMDP-Sponsored Trial Data Show Comparable Patient-Reported Outcomes and Survival Across Levels of Genetic Mismatch
Boom! FTC Squeezes Concessions from Cigna’s Express Scripts
Kosterina Launches Vinegars Nationwide in Walmart Stores
MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products
Cogensus Partners with Insight Senior Living and Integrated Senior to Advance Cognitive Wellness in Senior Communities
Dewpoint Therapeutics Doses First Patient in Phase 1a/2a Trial DPTX3186 for the Treatment of Advanced Solid Tumors, Focused on Gastric Cancer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions